UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 24, 2010

ProUroCare Medical Inc.
(Exact Name of Registrant as Specified in its Charter)

     
Nevada
000-51774
20-1212923
(State or other jurisdiction
(Commission
(IRS Employer
of incorporation)
File Number)
Identification No.)
 
6440 Flying Cloud Dr., Suite 101, Eden Prairie, Minnesota  55416
(Address of Principal Executive Offices)  (Zip Code)
 
(952) 476-9093
(Registrant’s Telephone Number, Including Area Code)
 
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
     
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 

Item 8.01  Other Events
 
On May 24, 2010, ProUroCare Medical Inc. issued a press release announcing that a de novo application for market clearance was filed in accordance with Section 513(f)(2) of the Federal Food, Drug and Cosmetic Act on May 21 st for the ProUroScan (PMI) system, following a May 19 th meeting with the FDA.  The full text of the press release is set forth in Exhibit 99.1 attached hereto and is incorporated by reference in this Current Report on Form 8-K as if fully set forth herein.
 
Item 9.01  Financial Statements and Exhibits.

(a)           Financial statements:  None

(b)           Pro forma financial information:  None

 
(c)
Shell Company Transactions:  None

(d)           Exhibits:  99.1   Press release dated May 24, 2010



 
 
 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.


 
ProUroCare Medical Inc.
     
     
Date: May 24, 2010
By
/s/ Richard C. Carlson             
   
      Richard C. Carlson
   
      Chief Executive Officer


 
 
 


EXHIBIT INDEX

                                

Exhibit No.   ITEM
   
99.1
Press Release dated May 24, 2010


 
 
 
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more ProUroCare Medical (CE) Charts.
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more ProUroCare Medical (CE) Charts.